Doctor profile · Federal record

Dr. Adam Bagley, M.D.

Rheumatology Physician (CMS: Rheumatology) · Orange Park, FL

  • NPI 1649595216
  • Accepts Medicare
  • MIPS 88.8 / 100 · 2023
  • 16 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2100 Kingsley Ave
Orange Park, FL 320735130
(904) 276-0001
fax (904) 276-5333

Credentials & registration

NPPES · NUCC
NPI registered
April 2010 — 16 yrs on file
Profile last updated
August 15, 2025
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Florida #ME123101

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1649595216. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
225,558
Distinct HCPCS
10
Medicare allowed
$3,689,678
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 138,260 48 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 36,631 83 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 23,750 60 $41
J9312 Injection, rituximab, 10 mg 8,650 40 $75
J0490 Injection, belimumab, 10 mg 5,719 14 $43
J1745 Injection, infliximab, excludes biosimilar, 10 mg 5,042 34 $33
J0897 Injection, denosumab, 1 mg 3,120 36 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 998 429 $124
36415 Insertion of needle into vein for collection of blood sample 627 257 $8
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 574 164 $60

In context: peer comparison

Among 3 peers in this city , average services per provider: 6,964. This provider delivers 32× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,933
Transactions
167
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 32 $493.96
Janssen Biotech, Inc. 15 $403.83
AstraZeneca Pharmaceuticals LP 11 $313.09
Novartis Pharmaceuticals Corporation 22 $299.63
UCB, Inc. 15 $252.86
ABBVIE INC. 24 $250.67
PFIZER INC. 23 $195.87
Alexion Pharmaceuticals, Inc. 2 $162.92
Boehringer Ingelheim Pharmaceuticals, Inc. 8 $142.31
ANI Pharmaceuticals, Inc. 3 $81.43
GlaxoSmithKline, LLC. 4 $67.63
SOBI, INC 3 $61.02
E.R. Squibb & Sons, L.L.C. 2 $34.30
Lilly USA, LLC 2 $28.62
Takeda Pharmaceuticals U.S.A., Inc. 1 $27.98

By nature of payment

Food and Beverage
$2,734
Education
$199

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,206
Patients
473
Total drug cost
$259,357
Drug Type Claims Patients Total cost
Prednisone Generic 209 107 $3,906
Hydroxychloroquine Sulfate Generic 197 81 $18,539
Gabapentin Generic 146 63 $5,476
Methotrexate (Methotrexate Sodium) Brand 143 59 $7,774
Duloxetine Hcl Generic 96 38 $1,993
Pregabalin Generic 94 31 $5,173
Sulfasalazine Generic 52 21 $956
Allopurinol Generic 51 17 $779
Leflunomide Generic 41 15 $2,587
Venlafaxine Hcl Er (Venlafaxine Hcl) Brand 34 0 $341

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Adam Bagley's medical specialty?
Dr. Adam Bagley practices Rheumatology Physician in Orange Park, FL.
Where does Dr. Adam Bagley practice?
Dr. Adam Bagley practices at 2100 Kingsley Ave, Orange Park, FL 320735130. Office phone: 9042760001.
What is Dr. Adam Bagley's NPI?
Dr. Adam Bagley's National Provider Identifier (NPI) is 1649595216, issued by NPPES.
Does Dr. Adam Bagley accept Medicare assignment?
Yes. Dr. Adam Bagley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adam Bagley commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.